Theragenics Corp.
5203 Bristol Industrial Way
Buford,
GA 30518
United States - Map
Phone: 770-271-0233
Fax: 678-482-4909
Web Site: http://www.theragenics.com
| Theragenics Corporation operates as a medical device company serving the cancer treatment and surgical markets. It operates in two business segments, Surgical Products and Brachytherapy Seed. The Surgical Products segment engages in the manufacture and distribution of wound closure products, which include sutures and other surgical products with applications in urology, veterinary, cardiology, orthopedics, and plastic surgery; and vascular access products consisting of various introducer sheaths, guidewires, and accessories used in interventional radiology, interventional cardiology, and vascular surgery. This segment also offers specialty needle products comprising coaxial needles, biopsy needles, access trocars, brachytherapy needles, guidewire introducer needles, spinal needles, disposable veress needles, and other needle-based products for use in cardiology, orthopedic, pain management, endoscopy, spine, urology, and veterinary applications. The Brachytherapy Seed segment involves in the production, marketing, and sale of TheraSeed, a palladium-103 prostate cancer treatment device; I-Seed, an iodine-125 based prostate cancer treatment device; and other related products and services. The company sells its products through third-party distributors and directly to physicians, hospitals, original equipment manufacturers, and other healthcare providers primarily in the United States and Europe. Theragenics Corporation was founded in 1981 and is based in Buford, Georgia. |
|
| Key Statistics |
| |
| | Pay | Exercised | Ms. M. Christine Jacobs , 58
Chairman, Chief Exec. Officer and Pres |
N/A
| N/A | Mr. Francis J. Tarallo , 49
Chief Financial Officer, Principal Accounting Officer, Treasurer and Pres of Brachytherapy Bus. |
N/A
| N/A | Mr. Michael F. Lang , 53
Pres of Galt Medical Corp |
$
284.00K | N/A | Ms. Janet Zeman , 53
Pres of CP Medical |
$
298.00K | N/A | Mr. Bruce W. Smith , 56
Exec. VP of Strategy & Bus. Devel. and Sec. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
0.06 (4.17%) 
Profile
